The Kitasato Institute, Tokyo, Japan.
Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(2):13-28. doi: 10.2183/pjab.87.13.
Discovered in the late-1970s, the pioneering drug ivermectin, a dihydro derivative of avermectin--originating solely from a single microorganism isolated at the Kitasato Institute, Tokyo, Japan from Japanese soil--has had an immeasurably beneficial impact in improving the lives and welfare of billions of people throughout the world. Originally introduced as a veterinary drug, it kills a wide range of internal and external parasites in commercial livestock and companion animals. It was quickly discovered to be ideal in combating two of the world's most devastating and disfiguring diseases which have plagued the world's poor throughout the tropics for centuries. It is now being used free-of-charge as the sole tool in campaigns to eliminate both diseases globally. It has also been used to successfully overcome several other human diseases and new uses for it are continually being found. This paper looks in depth at the events surrounding ivermectin's passage from being a huge success in Animal Health into its widespread use in humans, a development which has led many to describe it as a "wonder" drug.
伊维菌素是一种阿维菌素的二氢衍生物,于 20 世纪 70 年代末被发现,它仅来源于日本 Kitasato 研究所从日本土壤中分离出的单一微生物,对改善全世界数十亿人的生活和福利产生了不可估量的积极影响。最初作为兽药引入,它能杀死商业牲畜和伴侣动物体内外的各种寄生虫。很快人们发现,它非常适合对抗困扰世界贫困地区热带地区数百年的两种最具破坏性和毁容性的疾病。现在,它正被免费用作在全球消除这两种疾病的唯一工具。它还被用于成功治疗其他几种人类疾病,并且不断发现新的用途。本文深入探讨了伊维菌素从动物健康领域的巨大成功到在人类中广泛应用的过程中所发生的事件,这一发展促使许多人将其描述为一种“神奇”药物。